UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058940
Receipt number R000067407
Scientific Title A Study on the Effects of Using Digital Pen Tablets on Parent-Child Communication and the Promotion of Psychological Functioning
Date of disclosure of the study information 2025/08/30
Last modified on 2025/09/01 10:37:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study on the Effects of Using Digital Pen Tablets on Parent-Child Communication and the Promotion of Psychological Functioning

Acronym

A Study on the Effects of Using Digital Pen Tablets on Parent-Child Communication and the Promotion of Psychological Functioning

Scientific Title

A Study on the Effects of Using Digital Pen Tablets on Parent-Child Communication and the Promotion of Psychological Functioning

Scientific Title:Acronym

A Study on the Effects of Using Digital Pen Tablets on Parent-Child Communication and the Promotion of Psychological Functioning

Region

Japan


Condition

Condition

Healthy individuals (parents and children), Psychological stress reduction, Communication promotion

Classification by specialty

Adult Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In recent years, declining parent-child communication and psychological stress have become significant concerns. This study aims to examine the effects of collaborative drawing activities using digital pen tablets on the quality of parent-child relationships and psychological well-being through enhanced communication.

Basic objectives2

Others

Basic objectives -Others

Evaluate the effects of parent-child collaborative drawing activities using digital pen tablets on communication promotion and psychological functions.

Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Frequency and quality of parent-child communication at 12 weeks after intervention initiation

Key secondary outcomes

well-being


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

Joint digital art activities using a pen tablet by parent and child
The intervention period is 12 weeks

Interventions/Control_2

No treatment control

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

6 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Child: A healthy individual who is an elementary school student (ages 6 to 12) at the time of registration
Guardian: A healthy individual who is the guardian of an elementary school child aged 6 to 12 at the time of registration

Key exclusion criteria

Individuals unable to provide informed consent,Individuals with a history of neurological disorders,Individuals with severe visual impairment,Individuals currently participating in other clinical studies,Individuals for whom study participation is difficult

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Yasuyuki
Middle name
Last name Taki

Organization

Tohoku University

Division name

Smart Aging Research Center

Zip code

980-8575

Address

4-1 Seiryo-cho, Aoba-ku, Sendai City, Miyagi Prefecture,

TEL

022-717-8952

Email

yasuyuki.taki.c7@tohoku.ac.jp


Public contact

Name of contact person

1st name Makiko
Middle name
Last name Miyasaka

Organization

Tohoku University

Division name

Smart Aging Research Center

Zip code

980-8575

Address

4-1 Seiryo-cho, Aoba-ku, Sendai City, Miyagi Prefecture,

TEL

022-717-8952

Homepage URL


Email

makiko.miyasaka.e3@tohoku.ac.jp


Sponsor or person

Institute

Tohoku University

Institute

Department

Personal name



Funding Source

Organization

Wacom Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee Tohoku University Graduate School of Medicine

Address

2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan

Tel

0227284105

Email

ec-med@grp.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 08 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 08 Month 06 Day

Date of IRB


Anticipated trial start date

2025 Year 10 Month 01 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 08 Month 30 Day

Last modified on

2025 Year 09 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067407